EUCTR2019-001726-99-FR进行中（未招募）1 期
Comparison of corticosteroids versus placebo on duration of ventilatory support during severe acute exacerbations of COPD patients in the intensive care unit: a multicentre randomized controlled trial, CORTICOP. - CORTICOP
适应症
相关药物
试验速览
- 阶段
- 1 期
- 状态
- 进行中（未招募）
- 入组人数
- 440
研究概览
简要总结
暂无简介。
研究设计
- 研究类型
- Interventional clinical trial of medicinal product
入排标准
- 性别
- All
入选标准
- •1) Patients aged = 40 years, man or woman
- •2) Strongly suspected or documented COPD defined by all the following criterias :
- •- Persistent respiratory symptoms (dyspnoea, chronic cough or sputum production)
- •- History of exposure to a risk factor such as tobacco smoke
- •- If available, pulmonary function tests showing airflow limitation that is not fully reversible (post-bronchodilator ratio of forced expiratory volume in 1 s (FEV1)/forced vital capacity (FVC) ratio < 0.7)
- •3) ACRF, defined by the presence of the two following criteria:
- •- COPD exacerbation defined by a change in the patient baseline respiratory symptoms: dyspnoea, cough or sputum (volume or purulence) for at least 24 hours and requiring a change in regular respiratory medication
- •- Acute respiratory failure (defined by clinical signs of excessive muscle activity: polypnea = 30 breaths /min or use of accessory respiratory muscles) requiring ventilatory support, either invasive (implemented because of respiratory distress) or NIV (implemented because of hypercapnic acidosis with PaCO2 = 45 mmHg and pH = 7.35)
- •- Acute respiratory failure < 24h
- •4) Admission to an ICU, a step-up unit or a respiratory care unit
- •5) Written Informed consent from the patient or his surrogates. In patients who are not able to consent on admission (i.e., because of hypercapnic encephalopathy) and in absence of a substitute decision maker, an emergency inclusion procedure will be allowed, with a mandatory delayed consent
- •6) Affiliation to (or benefit from) French health insurance system.
- •Are the trial subjects under 18? no
- •Number of subjects for this age range:
- •F.1.2 Adults (18-64 years) yes
- •F.1.2.1 Number of subjects for this age range 90
- •F.1.3 Elderly (>=65 years) yes
- •F.1.3.1 Number of subjects for this age range 130
排除标准
- •Patient will not be included if they present any of the following criteria
- •1) Previous diagnostic of asthma, according to GINA” international guidelines
- •2) Recent use of systemic corticosteroids, defined by systemic corticosteroids use in the past 7 days
- •3) Contra-indication of systemic corticosteroids treatment: allergy to corticosteroids, uncontrolled severe arterial hypertension, uncontrolled diabetes mellitus, gastro-intestinal ulcer bleeding
- •4) Pneumothorax at randomization
- •5) Extracorporeal life support (ECMO or ECCO2R) at randomization
- •6) Moribund patient life expectancy < 3 months
- •7) Pregnancy
- •8) Patients protected by law
- •9) Exclusion period due to other clinical trial enrolment which can influence primary outcome
- •10) Previous inclusion in the present study.
研究者
相似试验
已完成
3 期
Comparison of the therapeutic effect of corticosteroid injection with hypertonic dextrose in patients with knee osteoarthritisM17.0Bilateral primary osteoarthritis of kneeKnee Osteoarthritis.IRCT20191002044951N1Iran University of Medical Sciences54
招募中
3 期
Comparing the effectiveness of oral corticosteroids, and pineapple extract &palcebo in treating Ecchymosis and Edemarhinoplasty.IRCT20240426061576N1Esfahan University of Medical Sciences60
招募中
不适用
Comparative Effectiveness of corticosteroid preparation in sympathetic ganglion block on lymphedemaDiseases of the musculo-skeletal system and connective tissueKCT0000300Seoul National University Hospital66
招募中
不适用
The effect of local corticosteroid with needling in the treatment of tennis elbowTennis Elbow.Lateral epicondylitisIRCT2017010531559N1Vice Chancellor for reseach of Yazd Azad University of Medical Sciences30
已完成
不适用
Comparing the effect of corticosteroid injections and platelet rich plasma on the treatment of shoulder tendinopathyShoulder Tendinopathy.rotator cuff syndrome rotator cuff or supraspinatous tear or rupture (complete ) ( incomplete ) not specified as traumaticM75.1IRCT201302174251N9Iran University of Medical Sciences56